U.S. Markets closed

MacroGenics stock spikes from positive results of cancer drug trial

Sara Gilgore
MacroGenics stock spikes from positive results of cancer drug trial

The successful late-stage trial is a big victory for the Rockville biotech, which focuses on antibody-based therapeutics to treat cancer.